Abstract:The gut microbiota has been implicated in immunoglobin A nephropathy (IgAN) because the intestinal immune response is assumed to be one of the disease triggers. Since the microbial composition is heritable, we hypothesize that genetic variants controlling gut microbiota composition may be associated with susceptibility to IgAN or clinical phenotypes. A total of 175 gut-microbiome-associated genetic variants were retrieved from the Genome-Wide Association Study (GWAS) Catalog. Genetic associations were examined in 1,511 patients with IgAN and 4,469 controls. Subphenotype associations and microbiome annotations were undertaken for a better understanding of how genes shaped phenotypes. Likely candidate microbes suggested in genetic associations were validated using 16S rRNA gene sequencing in two independent data sets with 119 patients with IgAN and 45 controls in total. Nine genetic variants were associated with susceptibility to IgAN. Risk genotypes of LYZL1 were associated with higher serum levels of galactose-deficient IgA1 (GdIgA1). Other significant findings included the associations between the risk genotype of SIPA1L3 and early age at onset, PLTP and worse kidney function, and AL365503.1 and more severe hematuria. Besides, risk genotypes of LYZL1 and SIPA1L3 were associated with decreased abundances of Dialister and Bacilli, respectively. Risk genotypes of PLTP and AL365503.1 were associated with increased abundances of Erysipelotrichaceae and Lachnobacterium, respectively. 16S data validated a decreased tendency for Dialister and an increased tendency for Erysipelotrichaceae in IgAN. In this pilot study, our results provided preliminary evidence that the gut microbiota in IgAN was affected by host genetics and shed new light on candidate bacteria for future pathogenesis studies. IMPORTANCE The gut microbiota and host genetics are implicated in the pathogenesis of IgAN. Recent studies have confirmed that microbial compositions are heritable (microbiome quantitative trait loci [QTL]). The relationship between host genetics and the microbiota and the role of the microbiota in IgAN are unclear. We retrieved the GWAS Catalog and associated microbiome QTL in IgAN, observing that nine genetic variants were associated with IgAN susceptibility and some clinical phenotypes. In a consistent way, the decreased abundance of Dialister was associated with higher serum levels of Gd-IgA1, and 16S rRNA gene analysis confirmed the decreased abundance of Dialister in IgAN. These data provided preliminary evidence that the gut microbiota in IgAN was affected by host genetics, which is a new strategy for future pathogenesis and intervention studies.

Combined genetic association and differed expression analysis of UBE2L3 uncovers a genetic regulatory role of (immuno) proteasome in IgA Nephropathy

Combined Genetic Association and Differed Expression Analysis of <i>UBE2L3</i> Uncovers a Genetic Regulatory Role of (Immuno)proteasome in IgA Nephropathy

Comprehensive Analysis of Aberrantly Expressed Profiles of Mrna and Its Relationship with Serum Galactose-Deficient IgA1 Level in IgA Nephropathy

Association of systemic lupus erythematosus susceptibility genes with IgA nephropathy in a Chinese cohort.

An Update on the Genetics of IgA Nephropathy

Uromodulin and progression of IgA nephropathy

Interaction Between GALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy.

Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis

Novel identified associations of RGS1 and RASGRP1 variants in IgA Nephropathy

Interaction between G ALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy

Cumulative Effects of Variants Identified by Genome-wide Association Studies in IgA Nephropathy

Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese

Genome-Wide Association Analysis of Protein-Coding Variants in IgA Nephropathy

Genetics of IgA nephrology: risks, mechanisms, and therapeutic targets

Interaction Between Variants of Two Glycosyltransferase Genes in IgA Nephropathy

Genome-Wide Meta-Analysis Identifies Three Novel Susceptibility Loci and Reveals Ethnic Heterogeneity of Genetic Susceptibility for IgA Nephropathy

Clinical Application of Polygenic Risk Score in IgA Nephropathy

Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy

From genomic insights to clinical hope: Targeting NEU1 in IgA nephropathy

WCN23-1071 GENOME-WIDE ASSOCIATION ANALYSIS OF PROTEIN CODING VARIANTS IN IGA NEPHROPATHY

Identification of new susceptibility loci for IgA nephropathy in Han Chinese